Introduction
Oligodendroglioma - Overview
Oligodendroglioma - Therapeutics Development
Oligodendroglioma - Therapeutics Assessment
Oligodendroglioma - Companies Involved in Therapeutics Development
Oligodendroglioma - Drug Profiles
Oligodendroglioma - Dormant Projects
Oligodendroglioma - Discontinued Products
Oligodendroglioma - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Oligodendroglioma, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Companies, 2021 (Contd..1)
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Target, 2021 (Contd..1)
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Mechanism of Action, 2021 (Contd..1)
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Oligodendroglioma - Pipeline by Alfasigma SpA, 2021
Oligodendroglioma - Pipeline by AngioChem Inc, 2021
Oligodendroglioma - Pipeline by Astellas Pharma Inc, 2021
Oligodendroglioma - Pipeline by Bayer AG, 2021
Oligodendroglioma - Pipeline by Boehringer Ingelheim International GmbH, 2021
Oligodendroglioma - Pipeline by Bristol Myers Squibb Co, 2021
Oligodendroglioma - Pipeline by CDG Therapeutics Inc, 2021
Oligodendroglioma - Pipeline by Chimerix Inc, 2021
Oligodendroglioma - Pipeline by Eli Lilly and Co, 2021
Oligodendroglioma - Pipeline by GtreeBNT Co Ltd, 2021
Oligodendroglioma - Pipeline by Immatics NV, 2021
Oligodendroglioma - Pipeline by Ipsen SA, 2021
Oligodendroglioma - Pipeline by Les Laboratoires Servier SAS, 2021
Oligodendroglioma - Pipeline by Nascent Biotech Inc, 2021
Oligodendroglioma - Pipeline by NMS Group SpA, 2021
Oligodendroglioma - Pipeline by Northwest Biotherapeutics Inc, 2021
Oligodendroglioma - Pipeline by Nuvation Bio Inc, 2021
Oligodendroglioma - Pipeline by Pfizer Inc, 2021
Oligodendroglioma - Pipeline by Taiho Oncology Inc, 2021
Oligodendroglioma - Pipeline by TheraBiologics Inc, 2021
Oligodendroglioma - Dormant Projects, 2021
Oligodendroglioma - Discontinued Products, 2021

List of Figures
Number of Products under Development for Oligodendroglioma, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

Companies Mentioned
• Alfasigma SpA
• AngioChem Inc
• Astellas Pharma Inc
• Bayer AG
• Boehringer Ingelheim International GmbH
• Bristol Myers Squibb Co
• CDG Therapeutics Inc
• Chimerix Inc
• Eli Lilly and Co
• GtreeBNT Co Ltd
• Immatics NV
• Ipsen SA
• Les Laboratoires Servier SAS
• Nascent Biotech Inc
• NMS Group SpA
• Northwest Biotherapeutics Inc
• Nuvation Bio Inc
• Pfizer Inc
• Taiho Oncology Inc
• TheraBiologics Inc